C. Buerki

发表

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies

Robert J. Gillies, Radka Stoyanova, Elai Davicioni, 2016, Oncotarget.

Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer

T. Triche, E. Davicioni, N. Erho, 2012, Journal of oncology.

Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers

T. Triche, E. Davicioni, N. Erho, 2011, Front. Gene..

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.

B. Trock, A. Partin, L. Marchionni, 2016, European urology.

Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings

A. Madabhushi, C. Magi-Galluzzi, E. Klein, 2019, European Radiology.

Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.

B. Hadaschik, D. Bonekamp, E. Davicioni, 2017, European urology focus.

A genomic classifier to improve prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

M. Kattan, C. Magi-Galluzzi, E. Klein, 2015 .

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.

Anirban P. Mitra, T. Triche, R. Karnes, 2013, The Journal of urology.

Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case Series.

Vidit Sharma, R. Karnes, K. Yousefi, 2018, Urology.

2239 CLINICAL AND GENOMIC ANALYSIS OF METASTATIC DISEASE PROGRESSION IN A BACKGROUND OF BIOCHEMICAL RECURRENCE

P. Black, E. Davicioni, N. Erho, 2013 .

The diverse genomic landscape of low−risk prostate cancer.

M. Cooperberg, P. Carroll, M. Arañes, 2017 .

Diagnostic du cancer au moyen de biomarqueurs

R. Jenkins, C. Buerki, A. Crisan, 2013 .

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy.

S. Freedland, F. Feng, R. Karnes, 2016, European urology.

Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus

J. Parker, R. McPherson, G. Wells, 2009, Arteriosclerosis, thrombosis, and vascular biology.

A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.

M. Kattan, C. Magi-Galluzzi, E. Klein, 2015, European urology.

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

Anirban P. Mitra, E. Bergstralh, T. Triche, 2013, Prostate Cancer and Prostatic Disease.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

P. Carroll, R. Stoyanova, A. Tewari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

Anirban P. Mitra, D. Tindall, T. Triche, 2013, PloS one.

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.

M. Cooperberg, P. Carroll, M. Arañes, 2018, European urology.

Arginine methyltransferase CARM 1 is a promoter-specific regulator of NF-j B-dependent gene expression

S. Saccani, G. Natoli, M. Covic, 2013 .

Acetylation of Poly(ADP-ribose) Polymerase-1 by p300/CREB-binding Protein Regulates Coactivation of NF-κB-dependent Transcription*

William Arbuthnot Sir Lane, M. Hottiger, P. Hassa, 2005, Journal of Biological Chemistry.

Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression

Mark T Bedford, Gioacchino Natoli, S. Saccani, 2005, The EMBO journal.

Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1*

M. Hottiger, P. Hassa, C. Buerki, 2003, Journal of Biological Chemistry.

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.

K. Hoadley, William Y. Kim, E. Davicioni, 2017, European urology.

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.

B. Trock, E. Klein, S. Freedland, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery

K. Badani, D. Albala, J. Hornberger, 2014, BJU international.

Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

Jianbo Li, Michael W Kattan, Elai Davicioni, 2016, Urology.

Cost‐effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer

M. Cooperberg, E. Davicioni, A. Dicker, 2017, Clinical genitourinary cancer.

Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy

C. Collins, A. Wyatt, Fan Mo, 2017, Scientific Reports.

‘ Clinical and Population Studies Functional Analysis of the Chromosome 9 p 21 . 3 Coronary Artery Disease Risk Locus

George Wells, Ruth McPherson, Olga Jarinova, 2009 .

Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65

H. Rehrauer, William Arbuthnot Sir Lane, M. Hottiger, 2008, Nucleic acids research.

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

Anirban P. Mitra, T. Triche, E. Davicioni, 2014, Journal of the National Cancer Institute.

Validation of a Genomic Classifier for Predicting Post-Prostatectomy Recurrence in a Community Based Health Care Setting.

K. Yousefi, E. Davicioni, V. Choeurng, 2016, The Journal of urology.

Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.

Elai Davicioni, Anirban P. Mitra, Peter C Black, 2016, The Journal of urology.

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

B. Trock, R. Stoyanova, M. Arañes, 2017, European urology.

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence

K. Yousefi, E. Davicioni, N. Erho, 2015, BJU international.

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients

K. Yousefi, E. Davicioni, V. Choeurng, 2016, Prostate Cancer and Prostatic Diseases.

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial

K. Haustermans, C. Decaestecker, I. Salmon, 2018, BMC Cancer.

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial

K. Haustermans, C. Decaestecker, I. Salmon, 2018, BMC Cancer.

Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis

Adam P. Dicker, Timothy N. Showalter, Robert B. Jenkins, 2015, PloS one.

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.

John W. Davis, R. Karnes, E. Davicioni, 2019, European urology oncology.

M. Kattan, C. Magi-Galluzzi, E. Klein, 2015, European urology.

Development and validation of a digital Gleason score biomarker signature for risk stratification of patients with prostate cancer.

T. Triche, E. Davicioni, I. Vergara, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence

K. Yousefi, E. Davicioni, N. Erho, 2015, BJU international.